The relationship between core body temperature and 3,4-methylenedioxymethamphetamine metabolism in rats: implications for neurotoxicity
A close relationship appears to exist between 3,4-methylenedioxymethamphetamine (MDMA)-induced changes in core body temperature and long-term serotonin (5-HT) loss.
We investigated whether changes in core body temperature affect MDMA metabolism.
Materials and methods
Male Wistar rats were treated with MDMA at ambient temperatures of 15, 21.5, or 30°C to prevent or exacerbate MDMA-induced hyperthermia. Plasma concentrations of MDMA and its main metabolites were determined for 6 h. Seven days later, animals were killed and brain indole content was measured.
The administration of MDMA at 15°C blocked the hyperthermic response and long-term 5-HT depletion found in rats treated at 21.5°C. At 15°C, plasma concentrations of MDMA were significantly increased, whereas those of three of its main metabolites were reduced when compared to rats treated at 21.5°C. By contrast, hyperthermia and indole deficits were exacerbated in rats treated at 30°C. Noteworthy, plasma concentrations of MDMA metabolites were greatly enhanced in these animals. Instrastriatal perfusion of MDMA (100 μM for 5 h at 21°C) did not potentiate the long-term depletion of 5-HT after systemic MDMA. Furthermore, interfering in MDMA metabolism using the catechol-O-methyltransferase inhibitor entacapone potentiated the neurotoxicity of MDMA, indicating that metabolites that are substrates for this enzyme may contribute to neurotoxicity.
This is the first report showing a direct relationship between core body temperature and MDMA metabolism. This finding has implications on both the temperature dependence of the mechanism of MDMA neurotoxicity and human use, as hyperthermia is often associated with MDMA use in humans.
Keywords3 4-Methylenedioxymethamphetamine (MDMA “Ecstasy”) 5-Hydroxytryptamine (5-HT serotonin) Hyperthermia Metabolism Neurotoxicity
The authors would like to thank “Fundación para la Investigación Médica Aplicada” (FIMA) and Ministerio de Educación y Ciencia for a fellowship to B.G.-A. and E.P., respectively. This work was supported by grants from the Ministerio de Educación y Ciencia (SAF2005-07919-C02–02), Ministerio de Sanidad y Consumo (PNSD), and the Spanish Networks of Excellence (ISCIII, Red de Trastornos Adictivos, and Red CIEN).
- Broening HW, Bowyer JF, Slikker W Jr (1995) Age-dependent sensitivity of rats to the long-term effects of the serotonergic neurotoxicant (+/−) 3,4-methylenedioxymethamphetamine (MDMA) correlates with the magnitude of the MDMA-induced thermal response. J Pharmacol Exp Ther 275:325–333PubMedGoogle Scholar
- Esteban E, O, Shea E, Camarero J, Sanchez V, Green RA, Colado MI (2001) 3,4-Methylenedioxymethamphetamine induces monoamine release, but not toxicity, when administered centrally at a concentration occurring following a peripherally injected neurotoxic dose. Psychopharmacology 154:251–260PubMedCrossRefGoogle Scholar
- Halliwell B (1992) Reactive oxygen species and the central nervous system. J Neurochem 59:1609–1623Google Scholar
- Jones DC, Lau SS, Monks TJ (2004) Thioether metabolites of 3,4-methylenedioxyamphetamine and 3,4-methylenedioxymethamphetamine inhibit human serotonin transporter (hSERT) function and simultaneously stimulate dopamine uptake into hSERT-expressing SK-N-MC cells. J Pharmacol Exp Ther 311:298–306PubMedCrossRefGoogle Scholar
- Learmonth DA, Vieira-Coelho MA, Benes J, Alves PC, Borges N, Freitas AP, Soares-da-Silva P (2002) Synthesis of 1-(3,4-dihydroxy-5-nitrophenyl)-2-phenyl-ethanone and derivatives as potent and long-acting peripheral inhibitors of catechol-O-methyltransferase. J Med Chem 45:685–695PubMedCrossRefGoogle Scholar
- Paxinos G, Watson C (1997) The rat brain in sterotaxic coordinates. Academic, New YorkGoogle Scholar
- Pizarro N, Ortuno J, Farre M, Hernandez-Lopez C, Pujadas M, Llebaria A, Joglar J, Roset PN, Mas M, Segura J, Cami J, de la Torre R (2002) Determination of MDMA and its metabolites in blood and urine by gas chromatography-mass spectrometry and analysis of enantiomers by capillary electrophoresis. J Anal Toxicol 26:157–165PubMedGoogle Scholar
- Yeh SY (1999) N-tert-butyl-alpha-phenylnitrone protects against 3,4-methylenedioxymethamphetamine-induced depletion of serotonin in rats. Synapse 31:169–177Google Scholar
- Zheng Y, Laverty R (1998) Role of brain nitic oxide in (+/−)3,4-methylenedioxymethamphetamine (MDMA)-induced neurotoxicity in rats. Brain Res 795:257–263Google Scholar